SCHEMBL3978869

SCHEMBL3978869

O=[N+]([O-])c1ccc(F)c(-c2ncco2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
HIF1A Q16665 1/20 0.46
KCNJ1 P48048 1/20 0.43
KCNH2 Q12809 1/20 0.43
TLR2 O60603 2/20 0.42
TLR1 Q15399 2/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
PTPRC P08575 3/20 0.40
S100A4 P26447 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MAPT P10636 2/20 0.40
AMY1A P0DUB6 1/20 0.40
CYP3A4 P08684 1/20 0.37
F7 P08709 1/20 0.37
F3 P13726 1/20 0.37
HTT P42858 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31463506 0.88 KCNJ1 (0.43) ALDH1A1HIF1AKCNJ1KCNH2NPC1
SCHEMBL1127509 0.88 KCNJ1 (0.43) ALDH1A1HIF1AKCNJ1KCNH2NPC1
SCHEMBL1644779 0.82 HSD17B10 (0.49) ALDH1A1KCNJ1KCNH2NPC1RAB9A
SCHEMBL28056041 0.82 PTPRC (0.44) ALDH1A1KCNJ1KCNH2NPC1RAB9A
SCHEMBL4265596 0.82 ALDH1A1 (0.49) ALDH1A1KCNJ1KCNH2PTPRCS100A4
SCHEMBL28062313 0.79 KCNJ1 (0.43) ALDH1A1KCNJ1KCNH2NPC1RAB9A
SCHEMBL8689842 0.79 HSD17B10 (0.49) ALDH1A1KCNJ1KCNH2PTPRCS100A4
SCHEMBL3888275 0.79 ALDH1A1 (0.49) ALDH1A1KCNJ1KCNH2PTPRCS100A4
SCHEMBL4910527 0.77 ALDH1A1 (0.67) ALDH1A1HIF1APTPRCS100A4TDP1
SCHEMBL28062384 0.76 KCNJ1 (0.39) ALDH1A1KCNJ1KCNH2RAB9APTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058919-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-05-07 WO disclosed
WO-2009058919-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-05-07 WO disclosed